Clinical Trial Update: Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating paclitaxel for gastric cancer and gastroesophageal junction adenocarcinoma; the trial includes metastatic/stage IV disease and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 1 | Status: ACTIVE_NOT_RECRUITING